{"name":"AFT Pharmaceuticals, Ltd.","slug":"aft-pharmaceuticals-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Combogesic® tablets","genericName":"Combogesic® tablets","slug":"combogesic-tablets","indication":"Acute pain management","status":"phase_3"},{"name":"Maxigesic IV","genericName":"Maxigesic IV","slug":"maxigesic-iv","indication":"Acute postoperative pain","status":"phase_3"}]}],"pipeline":[{"name":"Combogesic® tablets","genericName":"Combogesic® tablets","slug":"combogesic-tablets","phase":"phase_3","mechanism":"Combogesic combines paracetamol and ibuprofen to provide analgesic and anti-inflammatory pain relief through dual inhibition of prostaglandin synthesis and central pain pathways.","indications":["Acute pain management","Postoperative pain"],"catalyst":""},{"name":"Maxigesic IV","genericName":"Maxigesic IV","slug":"maxigesic-iv","phase":"phase_3","mechanism":"Maxigesic IV combines paracetamol and ibuprofen to provide analgesia and anti-inflammation through dual inhibition of prostaglandin synthesis and central pain modulation.","indications":["Acute postoperative pain","Moderate to severe pain requiring multimodal analgesia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPMm1QUnByU2pTUkoyTFF5cWU3T2s5UUhjU2xvVm5rNlZZbHF0WmN4dVJzZDAxdjVLSFE4NUFPRXAyMUVJUEZ1V2k4elpPUHRuQjlfT0lEQUczMXljZDhQM3BGeF9XclpQZTMwUERiOUFIa3J0bUY5SUc0THlxVDJmc0dfc0J4c1VyOUJQZndMZW51U0dJLW5OWnd5aXFiMC1DNUtzaTZ5M05yaTlkemw2Y0I0UzZ1MTdqNzNRek9RVGx6WXo5bXJWaA?oc=5","date":"2026-04-06","type":"deal","source":"TipRanks","summary":"AFT Pharmaceuticals posts record growth and strikes key U.S. distribution deal - TipRanks","headline":"AFT Pharmaceuticals posts record growth and strikes key U.S. distribution deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxQbWdZNFIzaklIYl9lTGdKMGxncG14RUttWDlTSWFGeWs0WnE1VWhzRUxoMF9IclpPZkJkZ3ZyUzY2Yko3ZVp0XzFJTC1WTVd0dllOYjlrRlNjaTdxQWgzZDJCRlRGbEc5OUZBeHBHU21mSW9rUDJjUWp4QjYyZ1ZSdVB5Zlh3blN2ajVzQTJ5emd0cU9Jc1lTTWJTWXl5Q2tYQUFKUm1JbnliSlI3Z251a3o1amlqdGlVa1BxR0dVN01FNzZablVvQTVyR2RNWV9ySVNXWDlIN1ZNWW02ZFBwUjdsN3VNc25QaEZoU3JKbFZJNWVnVVAtLVZiSGQ1X1d5dE42M01XLTdvTGZ2WTBuNVY4OGpGZTZVcFNfLUtreG1vRVRMZ25VSnF5VjR1Ukt4OHItVzI1SQ?oc=5","date":"2026-01-15","type":"pipeline","source":"GlobeNewswire","summary":"Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) - GlobeNewswire","headline":"Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNYklqV3ZnZmZ1MGVmRnVDN0lHRW8tM1NiUWRxREpLaXNLMl93eXRndWZ5UVROVHBqMmVOaTVVNU5nYm11ZUhtYklRczF4RmotWnlUWFQyb0dBR1hjZGlnblpkeWtCaVRRbldIc2F2NXBCeXJTS1FHOHdMV1JqcjBqLVMzdk1RZllIajZRV1dPbnIwMmNYRG40YWhsUzc3RmJwckVJRzkxWHJLZ0gzWERITk5VbzhLeUZaMjRyenBBbWVCT3RpNDJ3NDlmS0FhR1JM?oc=5","date":"2025-11-20","type":"earnings","source":"NZ Herald","summary":"AFT Pharma boss on revenue surge, Trump's shifting tariffs - NZ Herald","headline":"AFT Pharma boss on revenue surge, Trump's shifting tariffs","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-10-17","type":"earnings","source":"simplywall.st","summary":"Earnings Tell The Story For AFT Pharmaceuticals Limited (NZSE:AFT) As Its Stock Soars 27% - simplywall.st","headline":"Earnings Tell The Story For AFT Pharmaceuticals Limited (NZSE:AFT) As Its Stock Soars 27%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxQNUFmWllXYThXSklFR0J1QW9lZkQ2VVhLR0Q2MEFLQjQwWjc3VFJZdi1rcTg5NVZwRnpSNGJVUklPZFRoLW9CVjFFbzVoR2pYY21HOE11djFHZTV0VFV3QzZkSGFsRm9QSTBWbEpyYkxFSzRlVDJxQVBqcWkyY2ZlSnc1Vk9hZGJlRWdNZ3NrZ0ZjZDFxRGhJTWJaUUlGcVFMb0phMElDd014XzZpcnpsTFY1MXNYMkZpNERPRi0zeHRsVkg5cVdDZVM5MFFlRHNtOWR1dzdYMnRQY3l4T01zcnI5ZUZaZEQxam04MNIB8gFBVV95cUxPUDJFaEo1bmNLNkdiUzlzWGZOcEJ2OGhrLXVWNjUwSjhlM3ZhczQwTV9ZM2I4c3JZa0pBVjNzWTM5VkRTdmZjajFRMmFfSFpNa2FHOVRxMUEwNTl3bUwxLVlkX2VLSkRqQktaSFg0RjBMekV6dGpJdGR1aERaamcxVUEyM2dpaXU2S2FhX2tGSWpCZW5wYWVjSlZzZk5yUHU1MFpQOGtzYUJfcW1MaG0zdWc1UDRLNEhMQ0ZnTE5acjV5ZkxZY0dpeV9JOU1oek14S1pfenY1dlFVN0l3U2pjNXZqeVVsOHlYREMyOURXVUlYZw?oc=5","date":"2025-10-16","type":"pipeline","source":"simplywall.st","summary":"Is AFT Pharmaceuticals Limited's (NZSE:AFT) Latest Stock Performance A Reflection Of Its Financial Health? - simplywall.st","headline":"Is AFT Pharmaceuticals Limited's (NZSE:AFT) Latest Stock Performance A Reflection Of Its Financial Health?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-25","type":"earnings","source":"Herald Sun","summary":"Aft Pharma sticks with ambitious revenue target - Herald Sun","headline":"Aft Pharma sticks with ambitious revenue target","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-25","type":"pipeline","source":"simplywall.st","summary":"We Think Shareholders May Want To Consider A Review Of AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Compensation Package - simplywall.st","headline":"We Think Shareholders May Want To Consider A Review Of AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Compensation Package","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQNkdNa3ptWi1iR1VieEdfaGRaOExjVUVpWXZtRjRHcVBOcEhQNWtXZmhHUXZESzZaa3lCaU9QV1o3RGRVNmJwN0NBbG9oODl6aW5RRWcwcXZIRXF4Q3o5TXhYazZBRzZ5dnQ0WXpNNHllSnNxX2pnQWxYQ3g1a0RfVmwxR2J3eHNkME9lcVJSdFpYNUpfUzdVX1ZGLXZKdjlyMjd2QTZqYUo2eFQxMXc?oc=5","date":"2025-05-22","type":"earnings","source":"businessdesk.co.nz","summary":"AFT Pharmaceuticals hits $200m revenue milestone despite profit dip - businessdesk.co.nz","headline":"AFT Pharmaceuticals hits $200m revenue milestone despite profit dip","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPRG40cHVJZVoxczAwcXBSd1dZZ05DZWxfMUJEcUJ6MVdVVDVlMEtRdUl0VU05eDZraDhoby1xajFvN2d5RFFGZU1MY3RtRl9PNnUybTlPTlN5SjVtUFdUSzhZOHhqdlpCcEYwUURLS3V2M3ZUTFJxaXB2amt5TGdyanhKc1IwVEJBa2NkbkpvRzdJWmZuZ0s0dTVPMHAwSEJYZGdfZkVGVDgtQjRtMS1tVjVaZ3dUMS04UzFwN3d6cw?oc=5","date":"2023-10-18","type":"regulatory","source":"Reuters","summary":"Hyloris Pharma wins US FDA approval for pain treatment - Reuters","headline":"Hyloris Pharma wins US FDA approval for pain treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxORWFUMzdlVmgtMXJEVXNJbEg0RElVTlhZeXJYcVYzbldOTHprTGpZaGFickpLYmZEVGJ5Y25wTjQ1ZGxpbW05cklYVkVhb0U0Qnp5Mm8zWHVQMVhqOG9yaWZMX2VsWEg1bEQxMmdGMEc3WGJTQWxqYllERkNsbmdfWFZRQl91bmhlNW9TNlRMZnBoR3Z6RG5MZw?oc=5","date":"2023-07-06","type":"pipeline","source":"intelligentinvestor.com.au","summary":"AFT Pharmaceuticals Ltd Ordinary Shares (NZX:AFT) - intelligentinvestor.com.au","headline":"AFT Pharmaceuticals Ltd Ordinary Shares (NZX:AFT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOanl1cmhOM2NWc2JLeFVYSzRueWxkRW5LdUUzbTRSaGFfY21MbTNfS1RlM0R4NmZoRkdpSm1sLVVTRHg4WkVkYnV4ZXYwOGlLOGJkdlVkNldPNUNEUUNRRjBQVlF1WDVwX0Z1V3Z5TDV5Snk2SzlfVWwwZ21MaHVmaW1zek5ydw?oc=5","date":"2022-10-24","type":"pipeline","source":"Yahoo Finance","summary":"The Global Dry Eye Syndrome Treatment Market size is expected to reach $6.5 billion by 2028, rising at a market growth of 4.5% CAGR during the forecast period - Yahoo Finance","headline":"The Global Dry Eye Syndrome Treatment Market size is expected to reach $6.5 billion by 2028, rising at a market growth o","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOX0s0VTdiUktjQUFPbmNMR0xoZ3pfdlRGV2Z3MlFfdmVFVXZRZFlKVWU5azFNandQOEF5NVRSWVg1NGNqUTNzSVd4cW41dnpXdVNYSTZHRXVTM0I3VVdDalhwOXRiWGFIUnYtU3Z0bEtYX05IRHgxMlUtLUlXYXdZNlVlRGNNVkxTZDJMeGhZTQ?oc=5","date":"2020-08-18","type":"pipeline","source":"marketscreener.com","summary":"AFT Pharmaceuticals Limited: Shareholders Board Members Managers and Company Profile | NZAFTE0001S4 - marketscreener.com","headline":"AFT Pharmaceuticals Limited: Shareholders Board Members Managers and Company Profile | NZAFTE0001S4","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}